1. Actualisation du rapport sur les anticoagulants en France : Etat des lieux en 2014 et recommandations de surveillance - Point d'information - ANSM : Agence nationale de sécurité du médicament et des produits de santé n.d.https://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Actualisation-du-rapport-sur-les-anticoagulants-en-France-Etat-des-lieux-en-2014-et-recommandations-de-surveillance-Point-d-information (accessed October 2, 2018).
2. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events–European Registry in Atrial Fibrillation (PREFER in AF);Kirchhof;Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol,2014
3. Les anticoagulants oraux. Haute Aut Santé n.d. https://www.has-sante.fr/jcms/c_2851086/fr/les-anticoagulants-oraux (accessed June 30, 2020).
4. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy;Ansell;Chest,2004
5. Initiation and continuation of oral anticoagulant prescriptions for stroke prevention in non-valvular atrial fibrillation: A cohort study in primary care in France;Collings;Arch Cardiovasc Dis,2018